|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"liou jp"
Showing items 41-65 of 136 (6 Page(s) Totally)
<< < 1 2 3 4 5 6 > >>
View [10|25|50] records per page
| 臺北醫學大學 |
2014 |
Denbinobin upregulates miR-146a expression and attenuates IL-1β-induced upregulation of ICAM-1 and VCAM-1 expressions in osteoarthritis fibroblast-like synoviocytes
|
Yang, CR;Shih, KS;Liou, JP;Wu, YW;Hsieh, IN;Lee, HY;Lin, TC;Wang, JH |
| 臺北醫學大學 |
2014 |
In vitro and in vivo anti-tumour effects of MPT0B014, a novel derivative aroylquinoline, and in combination with erlotinib in human non-small-cell lung cancer cells
|
Tsai, AC;Pai, HC;Wang, CY;Liou, JP;Teng, CM;Wang, JC;Pan, SL |
| 臺北醫學大學 |
2014 |
Indole-3-ethylsulfamoylphenylacrylamides: Potent histone deacetylase inhibitors with anti-inflammatory activity
|
Mehndiratta, S;Hsieh, YL;Liu, YM;Wang, AW;Lee, HY;Liang, LY;Kumar, S;Teng, CM;CR*, Yang;Liou, JP*. |
| 臺北醫學大學 |
2014 |
Intermediary Metabolite Precursor Dimethyl-2-Ketoglutarate Stabilizes Hypoxia-Inducible Factor-1α by Inhibiting Prolyl-4-Hydroxylase PHD2
|
Hou, P;Kuo, CY;Cheng, CT;Liou, JP;Ann, DK;Chen, Q |
| 臺北醫學大學 |
2014 |
K20E, an oxidative-coupling compound of methyl caffeate, exhibits anti-angiogenic activities through down-regulations of VEGF and VEGF receptor-2
|
Lee, HY;Wang, LT;Li, YH;Pan, SL;Chen, YL;Teng, CM;Liou, JP |
| 臺北醫學大學 |
2014 |
Orally active microtubule-targeting agent, MPT0B271, for the treatment of human non-small cell lung cancer, alone and in combination with erlotinib
|
Tsai, AC;Wang, CY;Liou, JP;Pai, HC;Hsiao, CJ;Chang, JY;Wang, JC;Teng, CM;Pan, SL. |
| 臺北醫學大學 |
2014 |
Preclinical anti-arthritic study and pharmacokinetic properties of a potent histone deacetylase inhibitor MPT0G009
|
Hsieh, IN;Liou, JP;Lee, HY;Lai, MJ;Li, YH;Yang, CR |
| 臺北醫學大學 |
2014 |
Tubulin inhibitors: a patent review
|
Liu, YM;Chen, HL;Lee, HY;Liou, JP |
| 臺北醫學大學 |
2014 |
A novel action mechanism for MPT0G013, a derivative of arylsulfonamide, inhibits tumor angiogenesis through up-regulaiton of TIMP3 expression
|
Wang, CY;Liou, JP;Tsai, AC;Lai, MJ;Liu, YM;Lee, HY;Wang, JC;SL*, Pan;CM*, Teng |
| 臺北醫學大學 |
2014 |
In vitro and in vivo antitumor effects of MPT0B014, a novel derivative aroylquinoline, and in combination with erlotinib in human non-small-cell lung cancer cells
|
Tsai, AC;Pai, HC;Wang, CY;Liou, JP;Teng, CM;Wang, JC;Pan, SL |
| 國家衛生研究院 |
2013-10 |
Histone deacetylase inhibition improved cardiac functions with direct antifibrotic activity in heart failure
|
Kao, YH;Liou, JP;Chung, CC;Lien, GS;Kuo, CC;Chen, SA;Chen, YJ |
| 國家衛生研究院 |
2013-09 |
MPT0B169, a new tubulin inhibitor, inhibits cell growth and induces G2/M Arrest in nonresistant and paclitaxel-resistant cancer cells
|
Lee, WH;Liu, HE;Chang, JY;Liou, JP;Huang, HM |
| 國家衛生研究院 |
2013-09 |
MPT0B098, a novel microtubule inhibitor that destabilizes the hypoxia-inducible factor-1α mrna through decreasing nuclear-cytoplasmic translocation of RNA-binding protein HuR [Erratum: Molecular Cancer Therapeutics. 2013 Jul;12(7):1202-1212.]
|
Cheng, YC;Liou, JP;Kuo, CC;Lai, WY;Shih, KH;Chang, CY;Pan, WY;Tseng, JT;Chang, JY |
| 國家衛生研究院 |
2013-09 |
Furanylazaindoles: Potent anticancer agents in vitro and in vivo
|
Lee, HY;Pan, SL;Su, MC;Liu, YM;Kuo, CC;Chang, YT;Wu, JS;Nien, CY;Mehndiratta, S;Chang, CY;Wu, SY;Lai, MJ;Chang, JY;Liou, JP |
| 國家衛生研究院 |
2013-07-08 |
1-arylsulfonyl-5-(N-hydroxyacrylamide)indolines histone deacetylase inhibitors are potent cytokine release suppressors
|
Lee, HY;Yang, CR;Lai, MJ;Huang, HL;Hsieh, YL;Liu, YM;Yeh, TK;Li, YH;Mehndiratta, S;Teng, CM;Liou, JP |
| 國家衛生研究院 |
2013-07-08 |
Inside Cover: 1-arylsulfonyl-5-(N-hydroxyacrylamide)indolines histone deacetylase inhibitors are potent cytokine release suppressors(ChemBioChem 10/2013)
|
Lee, HY;Yang, CR;Lai, MJ;Huang, HL;Hsieh, YL;Liu, YM;Yeh, TK;Li, YH;Mehndiratta, S;Teng, CM;Liou, JP |
| 國家衛生研究院 |
2013-07 |
MPT0B098, a novel microtubule inhibitor that destabilizes the hypoxia-inducible factor-1 alpha mRNA through decreasing nuclear-cytoplasmic translocation of RNA-binding protein HuR
|
Cheng, YC;Liou, JP;Kuo, CC;Lai, WY;Shih, KH;Chang, CY;Pan, WY;Tseng, JT;Chang, JY |
| 國家衛生研究院 |
2013-04 |
MPT0G066, a novel microtubule-destabilizing agent, induces cell apoptosis and potentiates antineoplastic effects of cisplatin in human ovarian cancer cells in vitro and in vivo
|
Chen, CH;Li, YC;Chang, LH;Liou, JP;Pan, SL;Teng, CM |
| 國家衛生研究院 |
2013-03-12 |
A novel synthetic microtubule inhibitor, MPT0B214 exhibits antitumor activity in human tumor cells through mitochondria-dependent intrinsic pathway
|
Chiang, NJ;Lin, CI;Liou, JP;Kuo, CC;Chang, CY;Chen, LT;Chang, JY |
| 國家衛生研究院 |
2013-02 |
Azatyrosinamides: Novel RAS-related anticancer agents
|
Wang, CL;Lee, O;Huang, CF;Li, EIC;Teng, CM;Pan, SL;Lian, JF;Chang, FS;Liou, JP;Wang, HP |
| 臺北醫學大學 |
2013 |
Di- and Tripeptide Mimetic Prodrugs of Levodopa: Systemic and Brain Bioavailability of D-Phenylglycine-L-Dopa, a Sustained Dopamine Releasing Prodrug
|
CL, Wang;YB, Fan;Lee, SE;Lian, JF;Liou, JP;Wang, HP |
| 臺北醫學大學 |
2013 |
Histone deacetylase inhibition improved cardiac functions with direct antifibrotic activity in heart failure
|
Kao, YH;Liou, JP;Chung, CC;Lien, GS;Kuo, CC;Chen, SA;Chen, YJ |
| 臺北醫學大學 |
2013 |
Di- and Tripeptide Mimetic Prodrugs of Levodopa: Systemic and Brain Bioavailability of D-Phenylglycine-L-Dopa, a Sustained Dopamine Releasing Prodrug
|
Wang, CL;Fan, YB;Lee, SE;Lian, JF;Liou, JP;Wang, HP |
| 臺北醫學大學 |
2013 |
Evaluation of the safety and efficacy of warfarin in Taiwanese patients
|
Kuo, LN;Liou, JP;Chen, HY;Chiang, YC;Wu, MT |
| 臺北醫學大學 |
2013 |
A novel synthetic microtubule inhibitor, MPT0B214 exhibits antitumor activity in human tumor cells through mitochondria-dependent intrinsic pathway
|
Chiang, NJ;Lin, CI;Liou, JP;Kuo, CC;Chang, CY;Chen, LT;Chang, JY |
Showing items 41-65 of 136 (6 Page(s) Totally)
<< < 1 2 3 4 5 6 > >>
View [10|25|50] records per page
|
